Magazine Article | February 1, 2022

Do Patients Really Want Hybrid Clinical Trials?

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader

COVID-19 has created a public that is more educated than ever before on vaccine development and the need for clinical research. That’s why Ken Getz was so surprised to learn that, according to his organization’s research, the pandemic did not have a measurable impact on the attitudes and perceptions that patients have about clinical trials.

"We saw high ratings in terms of the quality of patients’ experiences in clinical research along with a high willingness to repeat participation,” says Getz, the founder and board chair of the Center for Information and Study on Clinical Research Participation (CISCRP). However, despite the industry shift toward patient-centric practices, “the fundamental measures around the burdens of participation and their influence on the decision to participate only changed slightly.”

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader